10 results
DEF 14A
AUPH
Aurinia Pharmaceuticals Inc
10 May 21
Definitive proxy
4:06pm
whether the work of WTW as compensation consultant raises any conflict of interest, taking into account relevant factors in accordance with SEC … not create any conflict of interest pursuant to the SEC rules and Nasdaq listing standards.
Factors Used in Determining Executive Compensation
Our
10-K/A
n4798l594
30 Apr 21
Annual report (amended)
4:16pm
PRE 14A
qfrouiaaj xh1qm7um
27 Apr 21
Preliminary proxy
4:32pm
10-K
EX-10.12
gmf8okd
24 Feb 21
Annual report
4:09pm
40FR12B/A
EX-99.41
c2s9jn063j
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
40FR12B/A
EX-99.36
hh041hd youhid0a6
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am
- Prev
- 1
- Next